APA (7th ed.) Citation

Wlodarczyk, B., Stasiak, M., & Malecka-Wojciesko, E. (2022). The diagnostic and prognostic value of apelin (APLN) and serum amyloid A3 (SAA3) adipocytokine measurement in patients with pancreatic ductal adenocarcinoma (PDAC) compared to chronic pancreatitis (CP) and healthy subjects. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 22, e58. https://doi.org/10.1016/j.pan.2022.06.150

Chicago Style (17th ed.) Citation

Wlodarczyk, Barbara, M. Stasiak, and E. Malecka-Wojciesko. "The Diagnostic and Prognostic Value of Apelin (APLN) and Serum Amyloid A3 (SAA3) Adipocytokine Measurement in Patients with Pancreatic Ductal Adenocarcinoma (PDAC) Compared to Chronic Pancreatitis (CP) and Healthy Subjects." Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.] 22 (2022): e58. https://doi.org/10.1016/j.pan.2022.06.150.

MLA (9th ed.) Citation

Wlodarczyk, Barbara, et al. "The Diagnostic and Prognostic Value of Apelin (APLN) and Serum Amyloid A3 (SAA3) Adipocytokine Measurement in Patients with Pancreatic Ductal Adenocarcinoma (PDAC) Compared to Chronic Pancreatitis (CP) and Healthy Subjects." Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.], vol. 22, 2022, p. e58, https://doi.org/10.1016/j.pan.2022.06.150.